The destructive combination of Scediosporium apiosperum lung disease and exuberant inflammation in cystic fibrosis
โ Scribed by Russell, Georgina K.; Gadhok, Radha; Simmonds, Nicholas J.
- Book ID
- 123036325
- Publisher
- Elsevier Science
- Year
- 2013
- Tongue
- English
- Weight
- 879 KB
- Volume
- 14
- Category
- Article
- ISSN
- 1526-0550
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Mucolytic treatment with rhDNase is part of the current therapy for cystic fibrosis (CF) lung disease. The Flutterเฎพ valve, a device for enhancing airway mucus clearance, has recently been approved for use in CF patients. Exhalation through the Flutterเฎพ valve leads to oscillations of expiratory airfl
The Epidemiologic Registry of Cystic Fibrosis provides clinical profiles for more than 6,800 patients and descriptions of practice patterns across eight European countries. Preliminary cross-sectional analysis has been performed by age and pulmonary function as an assessment of disease severity. In